The effects of PBRM1 deletion on tumor cells have been studied in human ccRCC tumor cell lines (36), but these experiments were in vitro and detached from the tumor microenvironment in vivo. The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.